What's new

Human medicines European public assessment report (EPAR): Respreeza, alpha1-proteinase inhibitor (human), Date of authorisation: 20/08/2015, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Respreeza, alpha1-proteinase inhibitor (human), Date of authorisation: 20/08/2015, Revision: 15, Status: Authorised

Mar 27, 2025 - 17:33
 0
Human medicines European public assessment report (EPAR): Respreeza, alpha1-proteinase inhibitor (human), Date of authorisation: 20/08/2015, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Respreeza, alpha1-proteinase inhibitor (human), Date of authorisation: 20/08/2015, Revision: 15, Status: Authorised
Read More

Tags:

Previous Article

Blimey, You Must Watch This Right Plucky Mini Give A Kraut GTI What For

Next Article

TraceGains uses AI to target food quality, safety

Related Posts

Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive

Orphan designation: Seladelpar Treatment of primary bil...

Mar 12, 2025  0

Human medicines European public assessment report (EPAR): Evkeeza, evinacumab, Date of authorisation: 17/06/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

PSUSA/00010511/202407

PSUSA/00010511/202407

Mar 19, 2025  0